vs

Side-by-side financial comparison of Beauty Health Co (SKIN) and Star Equity Holdings, Inc. (STRR). Click either name above to swap in a different company.

Beauty Health Co is the larger business by last-quarter revenue ($82.4M vs $56.8M, roughly 1.5× Star Equity Holdings, Inc.). Star Equity Holdings, Inc. runs the higher net margin — -3.0% vs -9.8%, a 6.8% gap on every dollar of revenue. On growth, Star Equity Holdings, Inc. posted the faster year-over-year revenue change (69.0% vs -1.3%). Beauty Health Co produced more free cash flow last quarter ($15.1M vs $-9.0M). Over the past eight quarters, Star Equity Holdings, Inc.'s revenue compounded faster (29.5% CAGR vs 0.6%).

Rare Beauty is an American cosmetics company founded by singer and actress Selena Gomez. Launched on September 3, 2020, the brand takes its name from Gomez’s third studio album, Rare (2020). Rare Beauty is sold through its official website, Sephora And Ulta beauty stores in multiple regions, including North America, Europe, Asia, and the Middle East.

Artists Equity is an American production company founded by actors and filmmakers Ben Affleck and Matt Damon in November 2022.

SKIN vs STRR — Head-to-Head

Bigger by revenue
SKIN
SKIN
1.5× larger
SKIN
$82.4M
$56.8M
STRR
Growing faster (revenue YoY)
STRR
STRR
+70.4% gap
STRR
69.0%
-1.3%
SKIN
Higher net margin
STRR
STRR
6.8% more per $
STRR
-3.0%
-9.8%
SKIN
More free cash flow
SKIN
SKIN
$24.0M more FCF
SKIN
$15.1M
$-9.0M
STRR
Faster 2-yr revenue CAGR
STRR
STRR
Annualised
STRR
29.5%
0.6%
SKIN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SKIN
SKIN
STRR
STRR
Revenue
$82.4M
$56.8M
Net Profit
$-8.1M
$-1.7M
Gross Margin
64.4%
Operating Margin
0.2%
-0.2%
Net Margin
-9.8%
-3.0%
Revenue YoY
-1.3%
69.0%
Net Profit YoY
21.5%
-192.1%
EPS (diluted)
$-0.02
$-0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SKIN
SKIN
STRR
STRR
Q4 25
$82.4M
$56.8M
Q3 25
$70.7M
$48.0M
Q2 25
$78.2M
$35.5M
Q1 25
$69.6M
$31.9M
Q4 24
$83.5M
$33.6M
Q3 24
$78.8M
$36.9M
Q2 24
$90.6M
$35.7M
Q1 24
$81.4M
$33.9M
Net Profit
SKIN
SKIN
STRR
STRR
Q4 25
$-8.1M
$-1.7M
Q3 25
$-11.0M
$-1.8M
Q2 25
$19.7M
$-688.0K
Q1 25
$-10.1M
$-1.8M
Q4 24
$-10.3M
$-585.0K
Q3 24
$-18.3M
$-846.0K
Q2 24
$202.0K
$-441.0K
Q1 24
$-679.0K
$-2.9M
Gross Margin
SKIN
SKIN
STRR
STRR
Q4 25
64.4%
Q3 25
64.6%
43.0%
Q2 25
62.8%
Q1 25
69.8%
Q4 24
62.7%
Q3 24
51.6%
50.5%
Q2 24
45.2%
Q1 24
59.4%
Operating Margin
SKIN
SKIN
STRR
STRR
Q4 25
0.2%
-0.2%
Q3 25
-8.8%
-3.4%
Q2 25
-3.5%
-0.6%
Q1 25
-17.3%
-5.4%
Q4 24
-8.6%
-0.4%
Q3 24
-27.3%
-1.2%
Q2 24
-24.4%
-0.5%
Q1 24
-20.9%
-9.0%
Net Margin
SKIN
SKIN
STRR
STRR
Q4 25
-9.8%
-3.0%
Q3 25
-15.6%
-3.7%
Q2 25
25.2%
-1.9%
Q1 25
-14.5%
-5.5%
Q4 24
-12.4%
-1.7%
Q3 24
-23.2%
-2.3%
Q2 24
0.2%
-1.2%
Q1 24
-0.8%
-8.6%
EPS (diluted)
SKIN
SKIN
STRR
STRR
Q4 25
$-0.02
$-0.49
Q3 25
$-0.09
$-0.54
Q2 25
$0.03
$-0.23
Q1 25
$-0.08
$-0.59
Q4 24
$-0.01
$-0.21
Q3 24
$-0.15
$-0.28
Q2 24
$-0.10
$-0.15
Q1 24
$-0.10
$-0.95

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SKIN
SKIN
STRR
STRR
Cash + ST InvestmentsLiquidity on hand
$10.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$61.1M
$65.7M
Total Assets
$499.8M
$113.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SKIN
SKIN
STRR
STRR
Q4 25
$10.3M
Q3 25
$15.4M
Q2 25
$16.8M
Q1 25
$16.6M
Q4 24
$17.0M
Q3 24
$15.8M
Q2 24
$14.7M
Q1 24
$20.4M
Total Debt
SKIN
SKIN
STRR
STRR
Q4 25
Q3 25
$363.4M
$6.5M
Q2 25
$363.1M
Q1 25
Q4 24
$552.2M
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
SKIN
SKIN
STRR
STRR
Q4 25
$61.1M
$65.7M
Q3 25
$65.7M
$67.8M
Q2 25
$74.0M
$40.1M
Q1 25
$46.1M
$39.5M
Q4 24
$51.8M
$40.4M
Q3 24
$59.7M
$42.9M
Q2 24
$69.2M
$42.6M
Q1 24
$63.3M
$44.3M
Total Assets
SKIN
SKIN
STRR
STRR
Q4 25
$499.8M
$113.2M
Q3 25
$503.6M
$117.1M
Q2 25
$507.6M
$55.6M
Q1 25
$673.8M
$53.2M
Q4 24
$685.7M
$52.6M
Q3 24
$699.5M
$52.6M
Q2 24
$711.8M
$52.6M
Q1 24
$844.7M
$52.6M
Debt / Equity
SKIN
SKIN
STRR
STRR
Q4 25
Q3 25
5.53×
0.10×
Q2 25
4.91×
Q1 25
Q4 24
10.66×
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SKIN
SKIN
STRR
STRR
Operating Cash FlowLast quarter
$15.2M
$-7.3M
Free Cash FlowOCF − Capex
$15.1M
$-9.0M
FCF MarginFCF / Revenue
18.3%
-15.8%
Capex IntensityCapex / Revenue
0.2%
3.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$37.2M
$-13.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SKIN
SKIN
STRR
STRR
Q4 25
$15.2M
$-7.3M
Q3 25
$9.6M
$-2.7M
Q2 25
$9.6M
$139.0K
Q1 25
$3.0M
$-802.0K
Q4 24
$16.5M
$-2.8M
Q3 24
$10.3M
$1.3M
Q2 24
$6.2M
$-4.3M
Q1 24
$-16.9M
$-1.8M
Free Cash Flow
SKIN
SKIN
STRR
STRR
Q4 25
$15.1M
$-9.0M
Q3 25
$9.6M
$-3.4M
Q2 25
$9.6M
$102.0K
Q1 25
$3.0M
$-808.0K
Q4 24
$16.4M
$-2.8M
Q3 24
$10.3M
$1.3M
Q2 24
$5.9M
$-4.3M
Q1 24
$-17.2M
$-1.8M
FCF Margin
SKIN
SKIN
STRR
STRR
Q4 25
18.3%
-15.8%
Q3 25
13.6%
-7.0%
Q2 25
12.2%
0.3%
Q1 25
4.2%
-2.5%
Q4 24
19.6%
-8.3%
Q3 24
13.1%
3.4%
Q2 24
6.5%
-12.0%
Q1 24
-21.1%
-5.3%
Capex Intensity
SKIN
SKIN
STRR
STRR
Q4 25
0.2%
3.0%
Q3 25
0.0%
1.3%
Q2 25
0.1%
0.1%
Q1 25
0.1%
0.0%
Q4 24
0.1%
0.1%
Q3 24
0.0%
0.0%
Q2 24
0.4%
0.0%
Q1 24
0.4%
0.0%
Cash Conversion
SKIN
SKIN
STRR
STRR
Q4 25
Q3 25
Q2 25
0.49×
Q1 25
Q4 24
Q3 24
Q2 24
30.70×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SKIN
SKIN

Consumables$57.7M70%
Delivery Systems$24.7M30%

STRR
STRR

Revenue From Other Contracts With Customers$27.6M49%
Other$24.3M43%
Energy Services Segment$4.9M9%

Related Comparisons